×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [7]
Faculty of Healt... [6]
THE STATE KEY LA... [5]
Authors
TAM KIN YIP [2]
WANG YITAO [1]
CHEN XIN [1]
KWOK HANG FAI [1]
YUAN ZHEN [1]
CHEN XIUPING [1]
More...
Document Type
Journal article [13]
Conference paper [1]
Review article [1]
Date Issued
2024 [1]
2023 [3]
2022 [2]
2021 [2]
2020 [1]
2018 [2]
More...
Language
英語English [14]
Source Publication
Journal of Pharm... [2]
ACS Combinatoral... [1]
ACS Combinatoria... [1]
ACS Nano [1]
Biomedicine and ... [1]
Cells [1]
More...
Indexed By
SCIE [12]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-10 of 15
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies
Journal article
Jin, Haochun, Cui, Dianxin, Fan, Yu, Li, Guodong, Zhong, Zhangfeng, Wang, Yitao. Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies[J]. Drug Discovery Today, 2024, 29(3), 103885.
Authors:
Jin, Haochun
;
Cui, Dianxin
;
Fan, Yu
;
Li, Guodong
;
Zhong, Zhangfeng
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
6
IF:
6.5
/
7.3
|
Submit date:2024/04/02
Antibodies
Bioaffinity Strategy
Drug Discovery
Natural Products
Small Molecule
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
Journal article
Zeng, Jiuping, Li, Mingxing, Zhao, Qianyun, Chen, Meijuan, Zhao, Long, Wei, Shulin, Yang, Huan, Zhao, Yueshui, Wang, Anqi, Shen, Jing, Du, Fukuan, Chen, Yu, Deng, Shuai, Wang, Fang, Zhang, Zhuo, Li, Zhi, Wang, Tiangang, Wang, Shengpeng, Xiao, Zhangang, Wu, Xu. Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases[J]. Journal of Pharmaceutical Analysis, 2023, 13(6), 545-562.
Authors:
Zeng, Jiuping
;
Li, Mingxing
;
Zhao, Qianyun
;
Chen, Meijuan
;
Zhao, Long
; et al.
Favorite
|
TC[WOS]:
13
TC[Scopus]:
14
IF:
6.1
/
6.8
|
Submit date:2024/01/02
Autoimmune disease
Inflammatory disease
RORγt
Small-molecule inhibitor
T helper 17
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
Review article
2023
Authors:
Zeng,Jiuping
;
Li,Mingxing
;
Zhao,Qianyun
;
Chen,Meijuan
;
Zhao,Long
; et al.
Favorite
|
TC[WOS]:
13
TC[Scopus]:
14
IF:
6.1
/
6.8
|
Submit date:2023/08/03
Autoimmune Disease
Inflammatory Disease
Rorγt
Small-molecule Inhibitor
t Helper 17
GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47
Journal article
Shan, Wenying, Chen, Lvqi, Xu, Hao, Zhong, Qinghao, Xu, Yinqiu, Yao, Hequan, Lin, Kejiang, Li, Xuanyi. GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47[J]. Frontiers in Chemistry, 2023, 11.
Authors:
Shan, Wenying
;
Chen, Lvqi
;
Xu, Hao
;
Zhong, Qinghao
;
Xu, Yinqiu
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
2
IF:
3.8
/
4.8
|
Submit date:2024/02/22
Artificial Intelligence
Compound-protein Interaction Prediction
Gcforest
Small-molecule Cd47 Inhibitors
Word2vec
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis
Journal article
Li, Junnan, Chen, Pengchen, Wu, Qiushuang, Guo, Libin, Leong, Ka Weng, Chan, Kin Iong, Kwok, Hang Fai. A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis[J]. Cellular and Molecular Life Sciences, 2022, 79(12), 614.
Authors:
Li, Junnan
;
Chen, Pengchen
;
Wu, Qiushuang
;
Guo, Libin
;
Leong, Ka Weng
; et al.
Favorite
|
TC[WOS]:
7
TC[Scopus]:
6
IF:
6.2
/
7.7
|
Submit date:2023/01/30
Antibody Therapy
Cell Death
Drug Target
Precision Oncology
Small Molecule
Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities
Journal article
Wang, Yi Ting, Lu, Jia Hong. Chaperone-Mediated Autophagy in Neurodegenerative Diseases: Molecular Mechanisms and Pharmacological Opportunities[J]. Cells, 2022, 11(14), 2250.
Authors:
Wang, Yi Ting
;
Lu, Jia Hong
Favorite
|
TC[WOS]:
25
TC[Scopus]:
24
IF:
5.1
/
6.0
|
Submit date:2022/08/24
Alzheimer’s Disease
Autophagy
Chaperone-mediated Autophagy
Hsc70
Huntington’s Disease
Lamp2a
Neurodegenerative Disease
Parkinson’s Disease
Small Molecule
Α-synuclein
Small molecules targeting ubiquitination to control inflammatory diseases
Journal article
Zheng-Qing Li, Xiuping Chen, Ying Wang. Small molecules targeting ubiquitination to control inflammatory diseases[J]. DRUG DISCOVERY TODAY, 2021, 26(10), 2414-2422.
Authors:
Zheng-Qing Li
;
Xiuping Chen
;
Ying Wang
Favorite
|
TC[WOS]:
5
TC[Scopus]:
4
IF:
6.5
/
7.3
|
Submit date:2021/12/08
Ubiquitin
Ubiquitination System
Inflammatory Diseases
Small Molecule Modulator
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
Journal article
Chen, Qiu Ling, Yin, Hao Ran, He, Qing Yu, Wang, Ying. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease[J]. Biomedicine and Pharmacotherapy, 2021, 138, 111442.
Authors:
Chen, Qiu Ling
;
Yin, Hao Ran
;
He, Qing Yu
;
Wang, Ying
Favorite
|
TC[WOS]:
67
TC[Scopus]:
70
IF:
6.9
/
6.8
|
Submit date:2021/12/08
Inflammatory Bowel Disease
Nlrp3
Small Molecule Inhibitor
Targeted Therapy
Food bioactive small molecule databases: Deep boosting for the study of food molecular behaviors
Journal article
Yang,Zheng Fei, Xiao,Ran, Luo,Fei Jun, Lin,Qin Lu, Ouyang,Defang, Dong,Jie, Zeng,Wen Bin. Food bioactive small molecule databases: Deep boosting for the study of food molecular behaviors[J]. Innovative Food Science and Emerging Technologies, 2020, 66, 102499.
Authors:
Yang,Zheng Fei
;
Xiao,Ran
;
Luo,Fei Jun
;
Lin,Qin Lu
;
Ouyang,Defang
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
5
IF:
6.3
/
6.5
|
Submit date:2021/03/02
Bioactive Data
Food
Food Compound
Food Database
Small Molecule
Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics
Journal article
Zhang W., Hu X., Chakravarty H., Yang Z., Tam K.Y.. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics[J]. ACS Combinatorial Science, 2018, 20(11), 660-671.
Authors:
Zhang W.
;
Hu X.
;
Chakravarty H.
;
Yang Z.
;
Tam K.Y.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
12
|
Submit date:2018/12/18
Cancer
High-throughput Screening
Pyruvate Dehydrogenase Kinase 1
Small Molecule Inhibitors
Warburg Effect